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eight skeletal sites and knee structure in asymptomatic young to middle-
aged females without any clinical signs of osteoarthritis.
Methods: One hundred and sixty healthy, females (29–50yr) without
symptoms of osteoarthritis underwent magnetic resonance imaging of
the knee. BMD was measured at the spine, hip, total body and forearm by
dual energy x-ray absorptiometry, and SoS, BUA and SI were measured at
the calcaneus by quantitative ultrasound (QUS). BMD and QUS measures
were tested for an association with cartilage volume, defects, and bone
marrow lesions (BMLs).
Results: medial cartilage volume was positively associated with bmd
at the total body, femoral neck, and ward’s triangle (all p < 0.05).
Non-signiﬁcant associations in the same direction existed at the spine
(p =0.07), and trochanter (p = 0.10). Findings in the lateral compartment
were similar. The presence of medial cartilage defects showed a non-
signiﬁcant association with bmd at the spine (p = 0.05). Bmd was not
associated with lateral cartilage defects or bmls. No associations were
observed with qus measures at the calcaneus.
Conclusions: Whilst site-speciﬁc BMD is associated with cartilage
volume at the knee in asymptomatic females aged 29–50yr, peripheral
BMD measures, and QUS measures of the calcaneus, showed no
associations with knee structure. These data suggest that the association
between cartilage volume and axial/ lower limb BMD may relate to
common local, possibly biomechanical, factors.
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Purpose: Intra-articular hyaluronic acid (HA) injections are a non-
surgical palliative treatment for knee osteoarthritis (OA) that have the
potential to reduce pain and improve functional ability. However, not all
patients that receive HA injections have a beneﬁcial response. Several
different HA formulations are available and a comparative analysis of
outcomes is lacking in the literature. The purpose of this study was
to quantify the functional beneﬁt of two different HA formulations for
individuals with knee OA.
Methods: The Knee Outcome Survey (KOS) of 378 patients who received
HA injections for knee OA were retrospectively analyzed. Baseline
scores prior to injection and scores 4–6 weeks after the ﬁrst injection
were compared between subjects who received 4 Supartz injections
(n = 220) or a single Synvisc-One injection (n =158). Responders to the
HA injections were operationally deﬁned by two methods: 1) individuals
who had a KOS change score greater than 11 points, the minimally
detectable difference for the KOS, or 2) patients who showed any
magnitude increase in KOS scores. Self-reported knee function, ranked
as “Severely Abnormal”, “Abnormal”, or “Nearly Normal”, was evaluated
at baseline. Change in pain (0–5 scale) was compared between injection
types and between groups created based on the self-reported knee
function at baseline. A repeated measures ANOVA was used to assess
change in KOS score between injection types. Chi-square analysis was
used to determine differences in the responder rate between injection
types and determine if there was a relationship between change in pain
and injection type or between change in pain and baseline self-reported
knee function.
Results: There was a signiﬁcant improvement of 5.77 (SD 13.83) points
in KOS scores between baseline and follow-up (p< 0.001), although no
difference was found in KOS change scores between Supartz or Synvisc-
One HA injections (p =0.95). 45% of individuals reported decreased pain
at follow-up (p < 0.001), with no difference between injection types
(p = 0.23). The ratio of responders to non-responders was 28/72 based
on the 11 point KOS change criterion and 66/34 based on any change in
KOS criterion. There was no difference in response rate between Supartz
and Synvisc-One based on the 11-point change (p =0.73) or any change
(p =0.83) in KOS scores. At baseline, 18, 122, and 237 patients classiﬁed
their knee function as Severely Abnormal, Abnormal, or Nearly Normal,
respectively. There was a signiﬁcant relationship between baseline self-
reported functional score and change in KOS score (p< 0.001) (Figure 1)
and responder rate using the 11 point change in KOS score criterion
(p < 0.001), with lower functional report at baseline corresponding to
an increased likelihood of improvement at follow-up. The relationship
between baseline self-reported functional score was not signiﬁcantly
related to the change in pain (p = 0.07) or responder rate using any
change in KOS score criterion (p =0.21).
Fig. 1.
Conclusions: Both HA formulations resulted in signiﬁcant, but relatively
small, improvements in KOS scores and pain. Patients who report their
knee function as worse at baseline have the greatest likelihood of larger
improvements in KOS scores and a tendency for greater reduction in
pain. This trend may be a characteristic of the ceiling effect in the
metrics used to analyze post-injection outcomes and future work should
assess other variables that may provide information on which subsets
of patients will have an optimal response. HA injections provide pain
relief and reduce disability in nearly 2/3 of patients and there was no
apparent functional beneﬁt to the single versus multi-dose regimens.
Patients with a wide degree of disability at baseline beneﬁt from HA
injections, but patients who are more disabled may experience a greater
functional improvement with this treatment. Funding for this study was
provided by NIH grant P20RR01645
304
CORRELATION BETWEEN RADIOGRAPHIC FINDINGS, SF-36 AND
WOMAC SCORES FOR EVALUATION OF KNEE OSTEOARTHRITIS
O. Chechik1, G. Segal2, Y. Kosashvili3, A. Haim4,1,1, R. Lador1, E.M. Debbi2,
M. Salai1, A. Mor2, A. Elbaz2. 1Sourasky Med. Ctr., Tel-Aviv, Israel;
2AposTherapy Res. Group, Herzliya, Israel; 3Assaf Harofeh Med. Ctr., Zeriﬁn,
Israel; 4Technion-Israel Inst. of Technology, Haifa, Israel
Purpose: Criteria that deﬁne disease severity in osteoarthritis (OA)
are essential for diagnosis and the evaluation of different treatment
interventions. At present, these evaluations rely mostly on radiographic
evaluation and subjective self-reported surveys. The validity of these
clinical tools, however, is loose. The purpose of the current study was to
evaluate the correlations between common clinical OA diagnostic tools in
order to determine the value of each. A secondary goal was to investigate
the inﬂuence of gender differences on the ﬁndings.
Methods: 518 patients with medial compartment knee OA were
evaluated using the Western Ontario and McMaster Osteoarthritis Index
(WOMAC) questionnaire, SF-36 Health Survey and plain radiographs. A
correlation analysis was performed between the different domains of
each and the radiographic scale.
Results: A signiﬁcant correlation was found between WOMAC pain,
stiffness and function scores and all SF-36 domains. Functional and
physical items were better correlated than mental, emotional and
stiffness items. In addition, signiﬁcant gender differences were found
in all domains tested. Poor correlations were found between the
radiographic severity of the disease and the domains of the clinical
surveys.
Conclusions: Radiographs are unreliable in determining symptomatic
severity of disease in knee OA, as they correlate poorly with pain and
function. While all domains of the SF-36 and WOMAC questionnaires
are correlated, functional and physical items of the questionnaires are
in greatest agreement. This may suggest that these domains provide the
most superior assessment of symptomatic knee OA.
